Duke Street Bio granted approval by European Medicines Agency to launch next-generation PARP1-selective inhibitor trial
September 24, 2024

September 24, 2024
September 18, 2024
September 16, 2024
September 11, 2024
September 6, 2024
August 27, 2024
August 21, 2024
August 20, 2024
August 20, 2024
April 24, 2026
Axithra today announced the appointment of Lars Kongsbak as Chief Executive Officer. With over 25 years of industry leadership, Kongsbak will lead the...
April 20, 2026
AxisOne combines artificial intelligence with milestone-based delivery to accelerate lab selection, tighten research execution, and close the accounta...
April 20, 2026
Membership deepens ENPICOM's commitment to advance AI and autonomous agent infrastructure for life sciences R&D ENPICOM, an innovative bioinformat...

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225